Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis

Affiliations

Comment

Fernando Bril et al. Ann Intern Med. 2017.

. 2017 Feb 7;166(3):230.

doi: 10.7326/L16-0629.

¹ From University of Florida and Malcom Randall Veterans Affairs Medical Center, Gainesville, Florida.

No abstract available

Comment on

Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.
Cusi K, Orsak B, Bril F, Lomonaco R, Hecht J, Ortiz-Lopez C, Tio F, Hardies J, Darland C, Musi N, Webb A, Portillo-Sanchez P. Cusi K, et al. Ann Intern Med. 2016 Sep 6;165(5):305-15. doi: 10.7326/M15-1774. Epub 2016 Jun 21. Ann Intern Med. 2016. PMID: 27322798 Clinical Trial.
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis.
Sutton SK. Sutton SK. Ann Intern Med. 2017 Feb 7;166(3):229. doi: 10.7326/L16-0627. Ann Intern Med. 2017. PMID: 28166554 No abstract available.
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis.
Thomas JA, Gupta R, Aithal GP. Thomas JA, et al. Ann Intern Med. 2017 Feb 7;166(3):229-230. doi: 10.7326/L16-0628. Ann Intern Med. 2017. PMID: 28166555 No abstract available.